MPMarisa Passarelli

Marisa Passarelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marisa Passarelli has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages

    by Rodrigo Tallada Iborra, Adriana Machado-Lima, Ligia Shimabukuro Okuda, Paula Ramos Pinto, Edna Regina Nakandakare, Ubiratan Fabres Machado, Maria Lucia Correa-Giannella, Russell Pickford, Tom Woods, Margaret A. Brimble, et al.


  • Open Access

    N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats

    by Karolline S. da Silva, Paula R. Pinto, Nelly T. Fabre, Diego J. Gomes, Karina Thieme, Ligia S. Okuda, Rodrigo T. Iborra, Vanessa G. Freitas, Maria H. M. Shimizu, Walcy R. Teodoro, et al.

    Background: Advanced glycation endproducts elicit inflammation. However, their role in adipocyte macrophage infiltration and in the development of insulin resistance, especially in the absence of the deleterious biochemical pathways that coexist in diabetes mellitus, remains unknown. We investigated the effect of chronic administration of advanced glycated albumin (AGE-albumin) in healthy rats, associated or not with N-acetylcysteine (NAC) treatment, on insulin sensitivity, adipose tissue transcriptome and macrophage infiltration and polarization. Methods: Male Wistar rats were intraperitoneally injected with control (C) or AGE-albumin alone, or, together with NAC in the drinking water. Biochemical parameters, lipid peroxidation, gene expression and protein contents were, respectively, determined by enzymatic techniques, reactive thiobarbituric acid substances, RT-qPCR and immunohistochemistry or immunoblot. Carboxymethyllysine (CML) and pyrraline (PYR) were determined by LC/mass spectrometry and ELISA. Results: CML and PYR were higher in AGE-albumin as compared to C. Food consumption, body weight, systolic blood pressure, plasma lipids, glucose, hepatic and renal function, adipose tissue relative weight and adipocyte number were similar among groups. In AGE-treated animals, insulin resistance, adipose macrophage infiltration and Col12a1 mRNA were increased with no changes in M1 and M2 phenotypes as compared to C-albumin-treated rats. Total GLUT4 content was reduced by AGE-albumin as compared to C-albumin. NAC improved insulin sensitivity, reduced urine TBARS, adipose macrophage number and Itgam and Mrc mRNA and increased Slc2a4 and Ppara. CD11b, CD206, Ager, Ddost, Cd36, Nfkb1, Il6, Tnf, Adipoq, Retn, Arg and Il12 expressions were similar among groups. Conclusions: AGE-albumin sensitizes adipose tissue to inflammation due to macrophage infiltration and reduces GLUT4, contributing to insulin resistance in healthy rats. NAC antagonizes AGE-albumin and prevents insulin resistance. Therefore, it may be a useful tool in the prevention of AGE action on insulin resistance and long-term complications of DM. Keywords: advanced glycation, adipose tissue, advanced glycated albumin, insulin resistance, diabetes mellitus, macrophage differentiation


  • Glycated albumin induces lipid infiltration in mice aorta independently of DM and RAS local modulation by inducing lipid peroxidation and inflammation

    by Diego Juvenal Gomes, Ana Paula Velosa, Ligia Shimabukuro Okuda, Fernanda Bueno Fusco, Karolinne Santana da Silva, Paula Ramos Pinto, Edna Regina Nakandakare, Maria Lucia Correa-Giannella, Tom Woods, Margaret Anne Brimble, et al.


  • Dietary interesterified fat enriched with palmitic acid induces atherosclerosis by impairing macrophage cholesterol efflux and eliciting inflammation

    by Milessa Silva Afonso, Maria Silvia Ferrari Lavrador, Marcia Kiyomi Koike, Dennys Esper Cintra, Fabiana Dias Ferreira, Valeria Sutti Nunes, Gabriela Castilho, Luiz Antonio Gioielli, Renata Paula Bombo, Sergio Catanozi, et al.


  • Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes

    by Maria Beatriz Monteiro, Karina Thieme, Daniele Pereira Santos-Bezerra, Márcia Silva Queiroz, Viktoria Woronik, Marisa Passarelli, Ubiratan Fabres Machado, Daniel Giannella-Neto, Maria Oliveira-Souza, Maria Lúcia Corrêa-Giannella


  • Open Access

    Aerobic exercise training enhances the in vivo cholesterol trafficking from macrophages to the liver independently of changes in the expression of genes involved in lipid flux in macrophages and aorta

    by Paula Ramos Pinto, Débora Dias Ferraretto Moura Rocco, Ligia Shimabukuro Okuda, Adriana Machado-Lima, Gabriela Castilho, Karolline Santana da Silva, Diego Juvenal Gomes, Raphael de Souza Pinto, Rodrigo Tallada Iborra, Guilherme da Silva Ferreira, et al.

    Regular exercise prevents and regresses atherosclerosis by improving lipid metabolism and antioxidant defenses. Exercise ameliorates the reverse cholesterol transport (RCT), an antiatherogenic system that drives cholesterol from arterial macrophages to the liver for excretion into bile and feces. In this study we analyzed the role of aerobic exercise on the in vivo RCT and expression of genes and proteins involved in lipid flux and inflammation in peritoneal macrophages, aortic arch and liver from wild type mice. Twelve-week-old male mice were divided into sedentary and trained groups. Exercise training was performed in a treadmill (15 m/min, 30 min/day, 5 days/week). Plasma lipids were determined by enzymatic methods and lipoprotein profile by fast protein liquid chromatography. After intraperitoneal injection of J774-macrophages the RCT was assessed by measuring the recovery of 3H-cholesterol in plasma, feces and liver. The expression of liver receptors was determined by immunoblot, macrophages and aortic mRNAs by qRT-PCR. 14C-cholesterol efflux mediated by apo A-I and HDL2 and the uptake of 3H-cholesteryl oleoyl ether (3H-COE)-acetylated-LDL were determined in macrophages isolated from sedentary and trained animals 48 h after the last exercise session. Body weight, plasma lipids, lipoprotein profile, glucose and blood pressure were not modified by exercise training. A greater amount of 3H-cholesterol was recovered in plasma (24 h and 48 h) and liver (48 h) from trained animals in comparison to sedentary. No difference was found in 3H-cholesterol excreted in feces between trained and sedentary mice. The hepatic expression of scavenger receptor class B type I (SR-BI) and LDL receptor (B-E) was enhanced by exercise. We observed 2.8 and 1.7 fold rise, respectively, in LXR and Cyp7a mRNA in the liver of trained as compared to sedentary mice. Macrophage and aortic expression of genes involved in lipid efflux was not systematically changed by physical exercise. In agreement, 14C-cholestrol efflux and uptake of 3H-COE-acetylated-LDL by macrophages was similar between sedentary and trained animals. Aerobic exercise in vivo accelerates the traffic of cholesterol from macrophages to the liver contributing to prevention and regression of atherosclerosis, independently of changes in macrophage and aorta gene expression.


  • Glycated Human Serum Albumin Isolated from Poorly Controlled Diabetic Patients Impairs Cholesterol Efflux from Macrophages: An Investigation by Mass Spectrometry

    by Gabriela Castilho, Camila H Sartori, Adriana Machado-Lima, Edna R Nakandakare, Maria Lucia C Corrêa-Giannella, Marco Roverso, Simona Porcu, Annunziata Lapolla, Pietro Traldi, Marisa Passarelli

    Advanced glycation end-products impair ABCA-1-mediated cholesterol efflux by eliciting inflammation, the generation of reactive oxygen species and endoplasmatic reticulum (ER) stress. The glycation level of human serum albumin (HSA) from type 1 and type 2 diabetic patients was determined by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry and related to possible impairment of ER function and cellular cholesterol efflux. Comparison of the MALDI spectra from healthy and diabetic subjects allowed us to determine an increased HSA mean mass of 1297 Da for type 1 and 890 Da for type 2. These values reflect a mean condensation of at least 8 glucose units and 5 glucose units, respectively. Mouse peritoneal macrophages were treated with HSA from control, type 1 and type 2 diabetic subjects in order to measure the expression of Grp78, Grp94, protein disulfide isomerase (PDI), calreticulin (CRT), and ABCA-1. 14C-cholesterol overloaded-J774 macrophages were treated with HSA from control and diabetic subjects and further incubated with apo A-1 to determine the cholesterol efflux. Combined analyses comprising HSA from type 1 and type 2 diabetic patients were performed in cellular functional assays. In macrophages, PDI expression increased 89% and CRT 3.4 times in comparison to HSA from the control subjects. ABCA-1 protein level and apo A-I-mediated cholesterol efflux were, respectively, 50% and 60% reduced in macrophages exposed to HSA from type 1 and type 2 diabetic patients when compared to that exposed to HSA from control subjects. We provide evidence that the level of glycation that occurs in albumin in vivo damages the ER function related to the impairment in macrophage reverse cholesterol transport, and so contributes to atherosclerosis in diabetes.


  • In Type 2 Diabetes Mellitus Glycated Albumin Alters Macrophage Gene Expression Impairing ABCA1‐Mediated Cholesterol Efflux

    by Adriana Machado‐Lima, Rodrigo T. Iborra, Raphael S. Pinto, Gabriela Castilho, Camila H. Sartori, Erika R. Oliveira, Ligia S. Okuda, Edna R. Nakandakare, Daniel Giannella‐Neto, Ubiratan F. Machado, et al.

    Advanced glycation end products (AGE) are elevated in diabetes mellitus (DM) and predict the development of atherosclerosis. AGE‐albumin induces oxidative stress, which is linked to a reduction in ABCA‐1 and cholesterol efflux. We characterized the glycation level of human serum albumin (HSA) isolated from poorly controlled DM2 (n = 11) patients compared with that of control (C, n = 12) individuals and determined the mechanism by which DM2‐HSA can interfere in macrophage lipid accumulation. The HSA glycation level was analyzed by MALDI/MS. Macrophages were treated for 18 h with C‐ or DM2‐HSA to measure the 14C‐cholesterol efflux, the intracellular lipid accumulation and the cellular ABCA‐1 protein content. Agilent arrays (44000 probes) were used to analyze gene expression, and the differentially expressed genes were validated by real‐time RT‐PCR. An increased mean mass was observed in DM2‐HSA compared with C‐HSA, reflecting the condensation of at least 5 units of glucose. The cholesterol efflux mediated by apo AI, HDL3, and HDL2 was impaired in DM2‐HSA‐treated cells, which was related to greater intracellular lipid accumulation. DM2‐HSA decreased Abcg1 mRNA expression by 26%. Abca1 mRNA was unchanged, although the final ABCA‐1 protein content decreased. Compared with C‐HAS‐treated cells, NADPH oxidase 4 mRNA expression increased in cells after DM2‐HSA treatment. Stearoyl‐Coenzyme A desaturase 1, janus kinase 2, and low density lipoprotein receptor mRNAs were reduced by DM2‐HSA. The level of glycation that occurs in vivo in DM2‐HSA‐treated cells selectively alters macrophage gene expression, impairing cholesterol efflux and eliciting intracellular lipid accumulation, which contribute to atherogenesis, in individuals with DM2. J. Cell. Physiol. XXXX: XX–XX, 2015. © 2015 Wiley Periodicals, Inc. J. Cell. Physiol. 230: 1250–1257, 2015. © 2014 Wiley Periodicals, Inc., A Wiley Company


  • N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1

    by Juliana T. Machado, Rodrigo T. Iborra, Fernanda B. Fusco, Gabriela Castilho, Raphael S. Pinto, Adriana Machado-Lima, Edna R. Nakandakare, Antonio C. Seguro, Maria H. Shimizu, Sergio Catanozi, et al.


  • Open Access

    Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects

    by Camila C Leança, Valéria S Nunes, Natália B Panzoldo, Vanessa S Zago, Eliane S Parra, Patrícia M Cazita, Matti Jauhiainen, Marisa Passarelli, Edna R Nakandakare, Eliana C de Faria, et al.

    We have searched if plasma high density lipoprotein-cholesterol (HDL-C) concentration interferes simultaneously with whole-body cholesterol metabolism and insulin sensitivity in normal weight healthy adult subjects.